Comparing IPCW Models to Adjust for Informative Censoring During COVID ‐19 Using Data From the Clinical Practice Research Datalink

Documenti analoghi

• Demystifying Clone‐Censor‐Weighting to Study Treatment Initiation Windows: An Example Using Publicly Available Synthetic Medicare Claims Data
  di: Michael Webster‐Clark, et al.
  Pubblicazione: (2025)
• Validation of Clinical Practice Research Datalink (CPRD) Aurum Mother‐Baby Link
  di: Catherine Vasilakis‐Scaramozza, et al.
  Pubblicazione: (2025)
• Performance of the Self‐Controlled Case Series With Active Comparators for Drug Safety Signal Detection Using the Clinical Practice Research Datalink ( CPRD )
  di: Astrid Coste, et al.
  Pubblicazione: (2025)
• Patient Characteristics and Practice Variation Associated With New Community Prescription of Benzodiazepine and z‐Drug Hypnotics After Critical Illness: A Retrospective Cohort Study Using the UK Clinical Practice Research Datalink
  di: Elizabeth T. Mansi, et al.
  Pubblicazione: (2024)
• Impact of COVID ‐19 Restrictions on Nationwide Antipsychotic Use: Results From the Trends in Drug Utilization During COVID ‐19 Pandemic in Turkey ( PANDUTI ‐ TR ) Study
  di: Caner Vizdiklar, et al.
  Pubblicazione: (2026)